PA4Health Physical Activity App Open Pilot Study for African American Women

Developing a Tailored, Theoretically-Driven Smartphone Physical Activity Intervention for African American Women

Test the acceptability of a smartphone physical activity app for African American women

Study Overview

Detailed Description

The goal of this aim is to collect data that guide the refinement of intervention components and structure to increase appeal to AA women. Fifteen physically inactive AA women will participate in a 12-week study examining the feasibility, acceptability, and usage of the PA4Health app. They will receive a Fitbit tracker to be worn during the trial. Following the trial, participants will complete self-report measures as well as a semi-structured interview to learn about their experience in using the app, any experienced difficulties, and recommendations for improving the acceptance and usage of the app.

Intervention components: The intervention components include: tailored daily text intervention text message, educational feature, goal setting and monitoring, and an activity locator that allow participants to enter their zip code and view available resources for physical activity.

Study Type

Interventional

Enrollment (Actual)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New York
      • New York, New York, United States, 10027
        • City University of New York School of Public Health & Health Policy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 64 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion: Eligible participants must:

  1. be ages 18-64
  2. identify as AA and female
  3. own a smartphone
  4. be able to provide consent
  5. not regularly physically active (i.e. less than 90 mins. of MVPA per week), 6) medically cleared for PA,

7) have a valid email address, and 9) no previous engagement in the study.

Exclusion: Individuals will be excluded if they report:

  1. physical limitations to PA engagement
  2. significant medical conditions (e.g., heart failure)
  3. planned surgery in the next 6 months,
  4. pregnant or plan to become pregnant in the next 6 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
System usability scale (SUS)-- app satisfaction
Time Frame: 8 weeks study
The SUS measures ability of technology software. High levels of usability and acceptability of the app will be determined by a score greater than 70 on the SUS. Information will be used for improvement of the software.
8 weeks study
Metada; collected through app system
Time Frame: 8weeks
This information will inform usage of patterns of participants, including how frequently the logged into the app system and the component of the app the more frequently or less frequently
8weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Accelerometer
Time Frame: Participants will wear this device for 7 consecutive days at baseline and at 8 weeks(end of the intervention)
actigraph data will be analyzed to explore potential changes over time objectively collected min/week of MVPA
Participants will wear this device for 7 consecutive days at baseline and at 8 weeks(end of the intervention)
Fitbit data
Time Frame: Participants will wear this device daily during the 8-week intervention
Fitbit data will be explored to estimate the effect of the intervention on mean steps/week over time
Participants will wear this device daily during the 8-week intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 25, 2023

Primary Completion (Estimated)

October 30, 2025

Study Completion (Estimated)

October 30, 2025

Study Registration Dates

First Submitted

June 28, 2022

First Submitted That Met QC Criteria

January 26, 2023

First Posted (Actual)

February 6, 2023

Study Record Updates

Last Update Posted (Actual)

August 22, 2025

Last Update Submitted That Met QC Criteria

August 18, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • CityUNYSPH
  • K23MD014164 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on PA4Health Open Pilot

Subscribe